Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Immunoglobulin repertoire sequencing of a large cohort of healthy controls

PROVIDER: PRJNA491287 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7842690.fastq.gz	Fastqsanger.gz
	SRR7842700.fastq.gz	Fastqsanger.gz
	SRR7842710.fastq.gz	Fastqsanger.gz
	SRR7842720.fastq.gz	Fastqsanger.gz
	SRR7842730.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 7077

Similar Datasets

Project description:Immunoglobulin repertoire of an HIV study cohort, including matched controls and subjects producing HIV broadly neutralizing antibodies

| PRJNA486667 | ENA

Homo sapiens

Project description:Immunoglobulin repertoire sequencing of hu420143

| PRJNA260976 | ENA

Immune repertoire after immunization as seen by next generation sequencing and proteomics

Project description:We study the repertoire of immunoglobulin sequences after immunization in a cohort of rats. Animals were immunized with dinitrophenol modified KLH or with recombinant human HuD. In the immune repertoire, and also in the matching proteomics data, we observe that the animals produce a repertoire that has many shared motifs for those immunized with the same antigen. Cluster analysis allows the samples to be segregated according to the immunogen used.

2017-10-04 | PXD006484 | Pride

MicroRNA expression differences in blood-derived CD19+ B cells of methotrexate treated rheumatoid arthritis patients

Project description:The aims of the study were to assess the global miRNA repertoire of peripheral blood CD19+ B cells, by high throughput sequencing, and to uncover miRNA expression differences between RA patients (newly-diagnosed and methotrexate treated) and healthy controls.

2021-04-28 | GSE168284 | GEO

Immune repertoire after immunization as seen by next generation sequencing and proteomics

Project description:We study the repertoire of immunoglobulin sequences after immunization in a cohort of rats. Animals were immunized with dinitrophenol modified KLH or with recombinant human HuD. In the immune reprtoire, and also in the matching proteomics data, we observe that the animals produce a repertoire that has many shared motifs for those immunized with the same antigen. Cluster analysis allows the samples to be segregated according to the immunogen used.

2017-10-04 | GSE98855 | GEO

Project description:Sequencing of the canine immunoglobulin repertoire

| PRJNA790470 | ENA

Project description:Healthy controls from the TB-DAR cohort

| PRJNA1374062 | ENA

Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencing

Project description:Immunoglobulin Repertoire Analysis in PGNMID

| PRJEB88838 | ENA

Homo sapiens

Project description:Immunoglobulin repertoire in multiple sclerosis

| PRJNA248411 | ENA

Protein Array Screening of Myelodysplastic Syndromes II

Project description:In a two-stage study we investigated levels of Immunoglobulin G (IgG) reactivity in plasma from Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) post MDS patients (59 and 16 cases respectively) as compared to healthy cohort (34). In Stage I we utilized high-throughput protein arrays (23 232 total signals, in duplicate) to identify proteins of high-interest. In Stage II we designed new protein arrays (352 total signals, in duplicate) to further focus on 25 of the proteins from Stage I and expanded to a larger cohort, including both male and female samples (161 MDS and 43 AML patients; 112 healthy controls). Stage I resulted in 35 proteins displaying increased IgG reactivity in patients as compared to the healthy controls (P< 4.3 x10-07, Bonferroni Corrected P<0.01). This protein subset included 14 proteins associated with cancer, 12 with apoptosis, and 3 with the NFAT Regulation canonical pathway. Using the focused arrays we performed a classification of MDS patients and healthy controls. Stage II subsequently identified a high-interest focused set of 3 proteins, namely AKT3, FCGR3A and ARL8B displaying aberrant increased reactivity in patient subgroups, in concordance with Stage I. Autoantibody reactivity against specific proteins provides complementary information to other known molecular signatures for MDS and may enhance our capabilities for detecting and classifying MDS. In the study presented here, MDS patients were classified into Stable, Transforming or AML post MDS (L) classes retrospectively. The different patients were compared to a healthy cohort to assess increased autoantibody reactivity to specific patients as opposed to healthy groups

2013-11-21 | GSE48154 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data